Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Esophagus/REST_pca_on_diff_genes.png) | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Liver | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Liver/REST_pca_on_diff_genes.png) | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Oral Cavity | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/OralCavity/REST_pca_on_diff_genes.png) | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Prostate | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Prostate/REST_pca_on_diff_genes.png) | BPH: Benign Prostatic Hyperplasia |
Skin | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Skin/REST_pca_on_diff_genes.png) | AK: Actinic keratosis |
cSCC: Cutaneous squamous cell carcinoma |
SCCIS:squamous cell carcinoma in situ |
Thyroid | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Thyroid/REST_pca_on_diff_genes.png) | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:19032049 | Prostate | BPH | negative regulation of oxidative stress-induced neuron death | 10/3107 | 19/18723 | 3.36e-04 | 2.52e-03 | 10 |
GO:190040716 | Prostate | BPH | regulation of cellular response to oxidative stress | 28/3107 | 89/18723 | 3.90e-04 | 2.85e-03 | 28 |
GO:190288216 | Prostate | BPH | regulation of response to oxidative stress | 30/3107 | 98/18723 | 4.16e-04 | 3.01e-03 | 30 |
GO:00620127 | Prostate | BPH | regulation of small molecule metabolic process | 79/3107 | 334/18723 | 5.17e-04 | 3.66e-03 | 79 |
GO:00519604 | Prostate | BPH | regulation of nervous system development | 100/3107 | 443/18723 | 6.02e-04 | 4.16e-03 | 100 |
GO:19012158 | Prostate | BPH | negative regulation of neuron death | 53/3107 | 208/18723 | 6.87e-04 | 4.58e-03 | 53 |
GO:00356013 | Prostate | BPH | protein deacylation | 32/3107 | 112/18723 | 1.03e-03 | 6.46e-03 | 32 |
GO:00060816 | Prostate | BPH | cellular aldehyde metabolic process | 20/3107 | 60/18723 | 1.14e-03 | 7.10e-03 | 20 |
GO:00064763 | Prostate | BPH | protein deacetylation | 29/3107 | 101/18723 | 1.59e-03 | 9.28e-03 | 29 |
GO:00987323 | Prostate | BPH | macromolecule deacylation | 32/3107 | 116/18723 | 1.94e-03 | 1.10e-02 | 32 |
GO:00107214 | Prostate | BPH | negative regulation of cell development | 45/3107 | 180/18723 | 2.49e-03 | 1.34e-02 | 45 |
GO:0035051 | Prostate | BPH | cardiocyte differentiation | 40/3107 | 156/18723 | 2.58e-03 | 1.38e-02 | 40 |
GO:00716928 | Prostate | BPH | protein localization to extracellular region | 82/3107 | 368/18723 | 2.59e-03 | 1.39e-02 | 82 |
GO:00093069 | Prostate | BPH | protein secretion | 80/3107 | 359/18723 | 2.89e-03 | 1.52e-02 | 80 |
GO:00518516 | Prostate | BPH | modulation by host of symbiont process | 19/3107 | 60/18723 | 2.94e-03 | 1.54e-02 | 19 |
GO:00355929 | Prostate | BPH | establishment of protein localization to extracellular region | 80/3107 | 360/18723 | 3.13e-03 | 1.63e-02 | 80 |
GO:00507088 | Prostate | BPH | regulation of protein secretion | 62/3107 | 268/18723 | 3.35e-03 | 1.73e-02 | 62 |
GO:190320210 | Prostate | BPH | negative regulation of oxidative stress-induced cell death | 17/3107 | 53/18723 | 4.11e-03 | 2.04e-02 | 17 |
GO:00454452 | Prostate | BPH | myoblast differentiation | 24/3107 | 84/18723 | 4.13e-03 | 2.04e-02 | 24 |
GO:19032093 | Prostate | BPH | positive regulation of oxidative stress-induced cell death | 8/3107 | 18/18723 | 5.17e-03 | 2.43e-02 | 8 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
REST | SNV | Missense_Mutation | | c.3189N>G | p.Ile1063Met | p.I1063M | Q13127 | protein_coding | deleterious(0) | probably_damaging(0.946) | TCGA-AO-A03T-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | SD |
REST | SNV | Missense_Mutation | novel | c.622N>A | p.Glu208Lys | p.E208K | Q13127 | protein_coding | tolerated(0.19) | probably_damaging(0.993) | TCGA-BH-A0HF-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD |
REST | SNV | Missense_Mutation | | c.1114G>C | p.Asp372His | p.D372H | Q13127 | protein_coding | deleterious(0.04) | probably_damaging(1) | TCGA-D8-A1JA-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | PD |
REST | SNV | Missense_Mutation | | c.2746N>A | p.Ser916Thr | p.S916T | Q13127 | protein_coding | tolerated(0.13) | benign(0.257) | TCGA-E9-A1R7-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | fareston | SD |
REST | insertion | Nonsense_Mutation | novel | c.662_663insAGCACCCTTCCCCTCC | p.Cys221Ter | p.C221* | Q13127 | protein_coding | | | TCGA-A7-A0CE-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
REST | insertion | Frame_Shift_Ins | novel | c.664_665insCAGATGATCCTGGAGT | p.Gly222AlafsTer10 | p.G222Afs*10 | Q13127 | protein_coding | | | TCGA-A7-A0CE-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
REST | insertion | Frame_Shift_Ins | novel | c.3029_3030insAGCCTGCT | p.Ile1011AlafsTer12 | p.I1011Afs*12 | Q13127 | protein_coding | | | TCGA-A8-A07R-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Ancillary | zoledronic | SD |
REST | insertion | In_Frame_Ins | novel | c.3031_3032insGAGGGAGCCACCTCC | p.Ile1011delinsArgGlySerHisLeuLeu | p.I1011delinsRGSHLL | Q13127 | protein_coding | | | TCGA-A8-A07R-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Ancillary | zoledronic | SD |
REST | insertion | Nonsense_Mutation | novel | c.3204_3205insGAAATTTAGGGTGGAGGGAGTATGGGAATTTTA | p.Ser1068_Phe1069insGluIleTerGlyGlyGlySerMetGlyIleLeu | p.S1068_F1069insEI*GGGSMGIL | Q13127 | protein_coding | | | TCGA-AR-A0TY-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | PD |
REST | insertion | Nonsense_Mutation | novel | c.960_961insTTGGGAGGCCAATATAGGCGGATTGCTTGAGCCC | p.Arg321LeufsTer10 | p.R321Lfs*10 | Q13127 | protein_coding | | | TCGA-B6-A0I8-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |